×

Antisense oligomers for treatment of conditions and diseases

  • US 10,683,503 B2
  • Filed: 09/05/2019
  • Issued: 06/16/2020
  • Est. Priority Date: 08/25/2017
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising an antisense oligomer that comprises a sequence selected from the group consisting of SEQ ID NOs:

  • 21-61, 64-67, 210-250, 253-256 and 304-379, and a pharmaceutically acceptable excipient.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×